DrugPatentWatch Database Preview
Profile for United States of America Patent: 7217713
US Patent Family Members and Approved Drugs for United States of America Patent: 7217713
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Apr 25, 2023 | Merck Sharp Dohme | DUTREBIS | lamivudine; raltegravir potassium |
➤ Try a Free Trial | Apr 21, 2023 | Merck Sharp Dohme | ISENTRESS | raltegravir potassium |
➤ Try a Free Trial | Apr 21, 2023 | Merck Sharp Dohme | DUTREBIS | lamivudine; raltegravir potassium |
➤ Try a Free Trial | Apr 21, 2023 | Merck Sharp Dohme | ISENTRESS HD | raltegravir potassium |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |